Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer

ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer

ESMO 2019: Patients with nmCRPC treated with apalutamide show 25 percent reduction in risk of death

ESMO 2019: Patients with nmCRPC treated with apalutamide show 25 percent reduction in risk of death

ESMO 2019: Men with prostate cancer can be spared radiotherapy after surgery

ESMO 2019: Men with prostate cancer can be spared radiotherapy after surgery

Long-term hormone tx increases mortality risk for men with low PSA after prostate surgery

Long-term hormone tx increases mortality risk for men with low PSA after prostate surgery

Trial finds high-dose radiation effective for men whose prostate cancer has spread

Trial finds high-dose radiation effective for men whose prostate cancer has spread

Semen miRNAs could be non-invasive biomarkers for prostate cancer

Semen miRNAs could be non-invasive biomarkers for prostate cancer

Link observed between fathering children by assisted reproduction and increased risk of prostate cancer

Link observed between fathering children by assisted reproduction and increased risk of prostate cancer

Resistance to immune checkpoint blocker drug linked to metabolic imbalance

Resistance to immune checkpoint blocker drug linked to metabolic imbalance

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated...

More from ecancer